Research Translation
Extended Release Buprenorphine in Correctional Settings Shows Increased Treatment Retention and Reduced Opioid Use
Findings from JCOIN’s New York University Research Hub Both the rate of opioid use and the rate of overdose following release from jail or prison are disproportionately high in justice-involved populations [1]. Although medications for opioid use disorder (MOUD) are proven to reduce the likelihood for post-release overdose, they are largely underutilized in correctional facilities…
Read MoreVideo Explainer: Extended-Release Buprenorphine in Correctional Settings
A recent study published in the Journal of the American Medical Association (JAMA) found improved treatment outcomes for individuals prescribed extended-release buprenorphine in jail settings. Learn more in the short video below.
Read MoreVideo Explainer: Opioid Use Disorder Stigma, Discrimination and Policy Attitudes
A 2020 study from NORC at the University of Chicago and Indiana University investigated attitudes about opioid use disorder (OUD) among young adults. The study found that stigma is associated with higher levels of discrimination towards people with OUD, and that younger adults had lower levels of stigma than older counterparts. Learn more in the…
Read MoreJCOIN Research Update: Opioid Use Disorder Stigma, Discrimination, and Policy Attitudes in a National Sample of U.S. Young Adults
Stigma and attitudes about addiction contribute to the availability and accessibility of treatment for individuals with substance use disorders. A 2020 study from NORC at the University of Chicago and Indiana University sought to understand attitudes about opioid use disorder among 190 young adults aged 19-29 across the United States. Key Findings: The study found…
Read MoreStates Policies to Expand Access to Substance Use Disorder Treatment during COVID-19
New Data from JCOIN’s Brown University Clinical Research Center Source: PDAPS The Prescription Drug Abuse Policy System (PDAPS) is an online resource, developed by a team at the Center for Public Health Law Research at Temple University, through a supplement to JCOIN’s Brown University Clinical Research Center (Hub), that provides data and information on state…
Read MoreA Large Proportion of U.S. Jails Don’t Provide MOUD to Pregnant People with OUD, New Study Finds
Medications for opioid use disorder (MOUD) have been a well-established treatment for pregnant people with opioid use disorder (OUD), yet little is known about the standard of care practices and access to medications within U.S. jails. To better understand this knowledge gap, the Advocacy and Research on Reproductive Wellness of Incarcerated People (ARRWIP) study, a…
Read MoreOffering Buprenorphine Prior to Release from Jail May Reduce Recidivism
Findings from JCOIN’s Massachusetts Research Hub Individuals leaving incarceration with opioid use disorder (OUD) are at a high risk for overdose, recidivism, and adverse health outcomes. Providing medication for opioid use disorder (MOUD) prior to incarceration and post-release is effective in reducing negative outcomes. Existing studies tend to examine how the use of methadone and/or…
Read MoreIssue Brief: Considerations for Initiation of OUD Medications for Patients Recently Released from Controlled Environments
Download the Issue Brief (PDF) Background People with a history of opioid use disorder (OUD) who were not being treated with medication for OUD at the time of release from incarceration will have varying degrees of opioid tolerance and physical dependence. These will depend on their opioid use just prior to incarceration (for relatively short…
Read MoreIssue Brief: Medications for Opioid and Alcohol Use Disorders: Research Insights for Criminal Justice Professionals
Key Takeaways Medications for Substance Use Disorders Are Effective Treatments. Methadone, buprenorphine, and naltrexone are FDA-approved medications for the treatment of opioid use disorder (OUD). Naltrexone, acamprosate, and disulfiram are FDA-approved medications for the treatment of alcohol use disorder (AUD). These medications are effective in reducing substance use and improving recovery outcomes. Patient Choice Matters.…
Read MoreIssue Brief: Treating Opioid Use Disorder in Justice-Involved Populations
Download the Issue Brief (PDF) Opioid use disorder (OUD) is a medical condition that is treatable. Individuals involved in the criminal justice system should be screened for OUD. Anyone with moderate to severe OUD should have access to medication treatment for OUD in all criminal justice settings and upon release. OUD is a treatable illness,…
Read More